Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

William E Carson

Showing results (11-20 of 272) with videos related to

Pageof 28
Sort By:
Surgical Oncology Clinics of North America|November 21, 2007
Current immunotherapeutic strategies in breast cancerWilliam E Carson, Margaret I Liang
Journal of Surgical Oncology|October 14, 2015
Surgical management of ovarian carcinoma metastatic to the breast and axilla: A role for metastasectomy?Kara K Rossfeld, William E Carson
Annals of the New York Academy of Sciences|January 16, 2010
Immune modulation with interleukin-21Neela S Bhave, William E Carson
Oncology (Williston Park, N.Y.)|February 15, 2012
Individualized local treatment strategies for in-transit melanomaAlicia M Terando, William E Carson
Journal for Immunotherapy of Cancer|May 16, 2014
Myeloid derived suppressor cells - a new therapeutic target in the treatment of cancerRobert Wesolowski, Joseph Markowitz, William E Carson
Cancer Immunology, Immunotherapy : CII|April 5, 2021
Bruton's tyrosine kinase: an emerging targeted therapy in myeloid cells within the tumor microenvironmentLogan Good, Brooke Benner, William E Carson
Transactions on Machine Learning Research|January 8, 2024
Estimating Potential Outcome Distributions with Collaborating Causal NetworksTianhui Zhou, William E Carson, David Carlson
Journal of Immunology (Baltimore, Md. : 1950)|July 22, 2005
CpG-containing oligodeoxynucleotides act through TLR9 to enhance the NK cell cytokine response to antibody-coated tumor cellsJulie M Roda, Robin Parihar, William E Carson
Clinical Case Reports|December 20, 2018
Concurrent phyllodes tumor, eccrine carcinoma, and multinodular goiter 20 years after radiotherapy for Hodgkin lymphomaKristen M Quinn, Gary Tozbikian, William E Carson
The Korean Journal of Hematology|April 5, 2011
NK cell-based immunotherapy for treating cancer: will it be promising?Duck Cho, Sang-Ki Kim, William E Carson
Pageof 28

Showing results (11-20 of 272) with videos related to

Sort By:
Pageof 28
Surgical Oncology Clinics of North America|November 21, 2007
Current immunotherapeutic strategies in breast cancerWilliam E Carson, Margaret I Liang
Journal of Surgical Oncology|October 14, 2015
Surgical management of ovarian carcinoma metastatic to the breast and axilla: A role for metastasectomy?Kara K Rossfeld, William E Carson
Annals of the New York Academy of Sciences|January 16, 2010
Immune modulation with interleukin-21Neela S Bhave, William E Carson
Oncology (Williston Park, N.Y.)|February 15, 2012
Individualized local treatment strategies for in-transit melanomaAlicia M Terando, William E Carson
Journal for Immunotherapy of Cancer|May 16, 2014
Myeloid derived suppressor cells - a new therapeutic target in the treatment of cancerRobert Wesolowski, Joseph Markowitz, William E Carson
Cancer Immunology, Immunotherapy : CII|April 5, 2021
Bruton's tyrosine kinase: an emerging targeted therapy in myeloid cells within the tumor microenvironmentLogan Good, Brooke Benner, William E Carson
Transactions on Machine Learning Research|January 8, 2024
Estimating Potential Outcome Distributions with Collaborating Causal NetworksTianhui Zhou, William E Carson, David Carlson
Journal of Immunology (Baltimore, Md. : 1950)|July 22, 2005
CpG-containing oligodeoxynucleotides act through TLR9 to enhance the NK cell cytokine response to antibody-coated tumor cellsJulie M Roda, Robin Parihar, William E Carson
Clinical Case Reports|December 20, 2018
Concurrent phyllodes tumor, eccrine carcinoma, and multinodular goiter 20 years after radiotherapy for Hodgkin lymphomaKristen M Quinn, Gary Tozbikian, William E Carson
The Korean Journal of Hematology|April 5, 2011
NK cell-based immunotherapy for treating cancer: will it be promising?Duck Cho, Sang-Ki Kim, William E Carson
Pageof 28